An internal standard for the quantification of 1-palmitoyl-2-hydroxy-sn-glycero-3-PC
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

1-Palmitoyl-d3-2-hydroxy-sn-glycero-3-PC

Item No. 28229

Technical Information
Formal Name
(7R)-4,7-dihydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphapentacosan-25,25,25-d3-1-aminium, inner salt, 4-oxide
CAS Number
2692624-19-2
Synonyms
  • 1-Hexadecanoyl-sn-glycero-3-Phosphatidylcholine-d3
  • 1-Hexadecanoyl-sn-glycero-3-Phosphocholine-d3
  • LPC-d3
  • 16:0/0:0(d3) Lyso-PC
  • 1-Palmitoyl-sn-glycero-3-Phosphocholine-d3
  • PC(16:0/0:0)-d3
  • 16:0/0:0-PC-d3
Molecular Formula
C24H47D3NO7P
Formula Weight
Purity
≥99% deuterated forms (d1-d3)
Formulation
A solid
Chloroform:Methanol (1:1): solubleDMF: solubleDMSO: solubleEthanol: 2 mg/mlPBS (pH 7.2): soluble
SMILES
O[C@@H](COP(OCC[N+](C)(C)C)([O-])=O)COC(CCCCCCCCCCCCCCC([2H])([2H])[2H])=O
InChi Code
InChI=1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m1/s1/i1D3
InChi Key
ASWBNKHCZGQVJV-MVIJBLFRSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Learn More About Leveraging Helper Lipids to Achieve Versatile LNPs
    READ THE ARTICLE
    Product Description

    1-Palmitoyl-d3-2-hydroxy-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1-palmitoyl-2-hydroxy-sn-glycero-3-PC (Item No. 10172) by GC- or LC-MS. 1-Palmitoyl-2-hydroxy-sn-glycero-3-PC is the ubiquitous lipid species generated following phospholipase A2 (PLA2) hydrolysis of phosphatidylcholine.1 It increases the production of reactive oxygen species (ROS) and decreases superoxide dismutase (SOD) and endothelial nitric oxide synthase (eNOS) protein levels and phosphorylation of ERK1/2 in human umbilical vein endothelial cells (HUVECs) when used at a concentration of 125 µM.2 1-Palmitoyl-2-hydroxy-sn-glycero-3-PC potentiates the secretion of IL-6, IL-1β, IL-12, and TNF-α in LPS-stimulated M1 macrophages, but has no effect on CD163, CD206, CD36, or IL-10 in LPS-stimulated M2 macrophages when used at concentrations of 0.3 and 1.0 µM.3 It increases TGF-β1 production and enhances Foxp3 protein levels in Treg cells in isolated human peripheral blood when used at a concentration of 10 µM.4 1-Palmitoyl-2-hydroxy-sn-glycero-3-PC enhances neutrophil function, bacterial clearance, and survival in mouse models of sepsis when administered at a dose of 10 mg/kg.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Balsinde, J., Winstead, M.V., and Dennis, E.A. Phospholipase A2 regulation of arachidonic acid mobilization. FEBS Lett. 531(1), 2-6 (2002).

    2. Choi, S., Park, S., Liang, G.H., et alSuperoxide generated by lysophosphatidylcholine induces endothelial nitric oxide synthase downregulation in human endothelial cells. Cell Physiol. Biochem. 25(2-3), 233-240 (2010).

    3. Qin, X., Qiu, C., and Zhao, L. Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation. Cell. Immunol. 289(1-2), 185-190 (2014).

    4. Hasegawa, H., Lei, J., Matsumoto, T., et alLysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-β production. Biochem. Biophys. Res. Commun. 415(3), 526-531 (2011).

    5. Yan, J.-J., Jung, J.-S., Lee, J.-E., et alTherapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 10(2), 161-167 (2004).